Fig. 4From: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trialHbA1c changes across T2DM patients with obesity (BMI > 25 kg/m2)Back to article page
